Dr. Aleksandar Obradovic, an associate research scientist at Columbia University Irving Medical Center's Department of Systems Biology, has received the 2023 Michelson Philanthropies & Science Prize for Immunology Grand Prize for his essay titled "Precision Immunotherapy – A Mechanistic Approach to Overcoming Treatment Resistance."

Dr. Obradovic's groundbreaking approach aims to tackle the challenge of treatment-resistant cancer by delivering a customized combination of drugs to patients, potentially leading to improved immunotherapy efficacy. The $30,000 prize, encourages Dr. Obradovic to continue his research and make significant strides towards enhancing patient outcomes.


About Michelson Philanthropies & Science Prize for Immunology:

The Michelson Philanthropies & Science Prize for Immunology is a $30K Grand Prize and $10K Finalist Prizes awarded annually to support promising early career investigators focused on transformative research in human immunology, with trans-disease applications to accelerate vaccine and immunotherapeutic discovery.

The 2024 Michelson Prizes will look for research aimed at tackling the current roadblocks that exist in human vaccine development and expanding our limited understanding of key immune processes that are fundamental to successful vaccine and immunotherapy development.

For more information about the prizes, please visit here.

Previous
Previous

Dr. Joshua Tan's Coronaviruses vs. Fusion Peptides Study

Next
Next

ePanel On Demand: Breakthrough Discoveries in Human Immunology